When c-MYC was overexpressed under the p53-deficient condition (hep-c-MYC/p53KO) by co-injection of pX330-p53, the CRISPR base p53 knockout vector [27], cancer developed rapidly, as compared to those promoted by c-MYC alone. Here, TP53 is linked to cancer.